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A commentary on
Commentary: Zika Virus: the Latest Newcomer
by Craig, A. T., Paterson, B. J., and Durrheim, D. N. (2016). Front. Microbiol. 7:1028. doi:
10.3389/fmicb.2016.01028
We really appreciate Craig et al. (2016) for their commended to our contribution to the current
knowledge about Zika Virus (ZIKV), and their comments to the possible relationship between
Guillain-Barre syndrome (GBS) and ZIKV infection (Saiz et al., 2016). Even more, we absolutely
agree with their interpretations and recommendations pointing to the necessity of further research
to accurately quantify the effect of enhanced surveillance related to ZIKV circulation and associated
risks. In fact, we clearly stated in the abstract of our review (Saiz et al., 2016) and throughout
the text, including our final remarks, that clarifying whether there is a causal link between ZIKV
infection and GBS is a currently unavoidable goal.
In this regard, recently, we have specifically addressed what it is currently known about ZIKV
infections in relation with neurological manifestations (Blázquez and Saiz, in press), and stated
that, beside the reported data pointing to a relationship between ZIKV infection and GBS, so far, a
causal association has not been yet solidly established.
GBS is a clinical syndrome of multiple autoimmune etiologies and the most common and severe
acute paralytic neuropathy (van den Berg et al., 2014; Willison et al., 2016). In in many cases GBS
appears to be associated with antecedent infectious diseases (Winner, 2001), and sporadic arboviral
infections with dengue virus, DENV (Garg et al., 2015; Simon et al., 2016), West Nile virus, WNV
(Sejvar, 2004), or chikungunya virus, CHIKV (Wielanek et al., 2007) have already been associated to
GBS. In fact, Malone et al. (2016) have suggested that the concomitant regional increase in DENV
and CHIKV infections may have contribute to the recently registered increase in GBS incidence.
In any case, and beyond the considerable efforts carried out by the scientific community and
the national and international health authorities focused on deciphering ZIKV infection and its
consequences, sufficient resources should be allocated to provide the necessary tools to evaluate the
potential mechanisms of ZIKV association to GBS.
AUTHOR CONTRIBUTIONS
All authors conceived the ideas presented in the article. J-CS led the drafting of the article with
inputs from all other contributors. AV-C led the submission process.
FUNDING
This work was supported by grant ZIKA-BIO from INIA to J-CS, and AGL2014-56518-JIN from
MINECO to MM, AV-C is a recipient of a “Contrato de formación postodoctoral” fromMINECO.
TM is a recipient of a “Formación de Personal Investigador (FPI)” pre-doctoral fellowship
from INIA.
Saiz et al. Zika: Guillain-Barrè Syndrome
REFERENCES
Blázquez, A. B., and Saiz, J.-C. (in press). Neurological manifestations of Zika
Virus infection. World J. Virol. Available online at: http://www.wjgnet.com/
esps/ArticleInPressDetail.aspx?id=26415
Craig, A. T., Paterson, B. J., and Durrheim, D. N. (2016). Commentary: Zika
virus: the latest newcomer. Front. Microbiol. 7:1028. doi: 10.3389/fmicb.201
6.01028
Garg, R. K.,Malhotra, H. S., Jain, A., andMalhotra, K. P. (2015). Dengue-associated
neuromuscular complications. Neurol. India 63, 497–516. doi: 10.4103/0028-
3886.161990
Malone, R. W., Homan, J., Callahan, M. V., Glasspool-Malone, J., Damodaran,
L., Schneider, A., et al. (2016). Zika virus: medical countermeasure
development challenges. PLoS Negl. Trop Dis. 10:e0004530. doi:
10.1371/journal.pntd.0004530
Saiz, J.-C., Vázquez-Calvo, A., Blázquez, A. B., Merino-Ramos, T., Escribano-
Romero, E., and Martín-Acebes, M. A. (2016). Zika virus: the latest newcomer.
Front. Microbiol. 7:496. doi: 10.3389/fmicb.2016.00496
Sejvar, J. J. (2004). West Nile virus and "poliomyelitis". Neurology 63, 206–207. doi:
10.1212/01.WNL.0000130361.62281.69
Simon, O., Billot, S., Guyon, D., Daures, M., Descloux, E., Gourinat, A. C., et al.
(2016). Early Guillain-Barre Syndrome associated with acute dengue fever. J.
Clin. Virol. 77, 29–31. doi: 10.1016/j.jcv.2016.01.016
van den Berg, B., Walgaard, C., Drenthen, J., Fokke, C., Jacobs, B. C.,
and van Doorn, P. A. (2014). Guillain-Barré syndrome: pathogenesis,
diagnosis, treatment and prognosis. Nat. Rev. Neurol. 10, 469–482. doi:
10.1038/nrneurol.2014.121
Wielanek, A. C., Monredon, J. D., Amrani, M. E., Roger, J. C., and Serveaux, J. P.
(2007). Guillain-Barre syndrome complicating a Chikungunya virus infection.
Neurological 69, 2105–2107. doi: 10.1212/01.wnl.0000277267.07220.88
Willison, H. J., Jacobs, B. C., and van Doorn, P. A. (2016). Guillain-Barré
syndrome. Lancet 388, 717–727. doi: 10.1016/S0140-6736(16)00339-1
Winner, J. B. (2001). Guillain Barré syndrome. Mol. Pathol. 54, 381–385. doi:
10.1136/mp.54.6.381
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Saiz, Blázquez, De Oya, Merino-Ramos, Martín-Acebes,
Escribano-Romero and Vázquez-Calvo. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 2 September 2016 | Volume 7 | Article 1398
